Featured

All Topics

Managing Cash Flow and Expenses in Life Sciences

Managing Cash Flow and Expenses in Life Sciences

In this article: Managing cash flow presents ongoing challenges for those in the life sciences, particularly those navigating pre-clinical research and early clinical stages. With significant resources devoted to research and development (R&D), precise cash tracking across R&D and general and administrative (G&A) categories is essential for sustaining growth and demonstrating financial responsibility. Distinguishing between […]

Tax Strategies Shaping Life Science Innovation

Tax Strategies Shaping Life Science Innovation

Life science companies, particularly those in the start-up or growth phase, are challenged with balancing their core mission, e.g., advancing scientific discovery, with the complex financial and tax issues that arise in the process. While pursuing breakthroughs in areas like cancer treatments or novel drugs, companies need to also ensure they retain enough capital to […]

Attestation Deadline for New York Medicaid PCMH Incentive Increase

Attestation Deadline for New York Medicaid PCMH Incentive Increase

AAFCPAs would like to make FQHC clients aware that the 2024-2025 state budget approved a Patient-Centered Medical Home (PCMH) incentive increase that provided additional funding to health centers. These payments, which were retroactive to April 1, 2024, included $2 per member per month (PMPM) for adult Medicaid patients and $4 PMPM for children under the […]

AAFCPAs Participates in Compliance Panel at NECANN Boston 2025 

AAFCPAs Participates in Compliance Panel at NECANN Boston 2025 

AAFCPAs’ Janice M. O’Reilly, CPA, CGMA and David McManus, CPA, CGMA will join Tony Gallo, Sapphire Risk Advisory Group, and Peter D’Agostino, Tenax Strategies, for an interactive panel discussion at the 2025 New England Cannabis Convention (NECANN) on key compliance issues faced by cannabis establishments. The opening day session will cover compliance and reporting requirements […]

M&A Activity Set to Increase in 2025 Amid Economic and Demographic Shifts

M&A Activity Set to Increase in 2025 Amid Economic and Demographic Shifts

After a period of slowed deal making driven by high interest rates and uncertainty, the M&A landscape could look very different in 2025. As the economy adjusts to changing tax policies, evolving market conditions, and demographic shifts, business owners may find new opportunities to buy or sell. For many, 2025 could be the year to […]

Kevin February 2025 Desk Memo

Kevin February 2025 Desk Memo

Clients frequently inquire about the potential impact of administrative changes on their financial plans and investments as well as our strategies for adapting to the current economic landscape. As we move through the year, we remain cautiously optimistic about the markets. Several indicators suggest that we could see positive performance provided certain conditions hold steady. […]

Promotions Celebrated at AAFCPAs

Promotions Celebrated at AAFCPAs

Boston, MA (February 25, 2025)—AAFCPAs, a preeminent 350+ employee CPA and consulting firm based in New England, is pleased to announce recent promotions across key areas of the firm. We continue to invest in the growth of our practice areas and multi-disciplinary expertise to address the evolving needs of our sophisticated client base, and this […]

BOI Reporting Update: Court Reinstates Requirements, FinCEN Extends Deadline to March 21, 2025

BOI Reporting Update: Court Reinstates Requirements, FinCEN Extends Deadline to March 21, 2025

On February 18, 2025, the U.S. District Court for the Eastern District of Texas reinstated the controversial BOI reporting mandate. Fortunately, the U.S. Department of the Treasury’s Financial Crimes Enforcement Network (FinCEN) granted extra time to file, extending the deadline for beneficial ownership information (BOI) reporting under the Corporate Transparency Act (CTA). Most reporting companies […]

Tax Planning For Life Sciences Amid Shifting Policies

Tax Planning For Life Sciences Amid Shifting Policies

Life Science Leader (February 11,2025) – In the life sciences sector, maintaining a strategic approach to tax planning has become increasingly complex, especially with ongoing regulatory changes affecting mergers, acquisitions, and how we treat research and development (R&D) expenses. Such tax policy shifts can directly affect corporate structure decisions, overall business strategy, and the ability […]